about
Vascular calcification in patients with type 2 diabetes: the involvement of matrix Gla protein.Association between metformin use and below-the-knee arterial calcification score in type 2 diabetic patients.Thyroid Function Tests in the Reference Range and Fracture: Individual Participant Analysis of Prospective Cohorts.Simplification of the HOSPITAL score for predicting 30-day readmissions.Blood cultures in the evaluation of uncomplicated cellulitis.Prospective validation and adaptation of the HOSPITAL score to predict high risk of unplanned readmission of medical patients.Polypharmacy and specific comorbidities in university primary care settings.Thyroid Hormone Therapy for Older Adults with Subclinical Hypothyroidism.[New guidelines for screening and management of familial dyslipidemia].Thyroid dysfunction and anaemia in a large population-based study.Mean platelet volume in the early phase of acute ischemic stroke is not associated with severity or functional outcome.Influence of peripheral vascular calcification on efficiency of screening tests for peripheral arterial occlusive disease in diabetes--a cross-sectional study.Association between subclinical thyroid dysfunction and change in bone mineral density in prospective cohorts.Hypertension is an independent predictor of mean platelet volume in patients with acute ischaemic stroke.Performance-based functional impairment and readmission and death: a prospective study.Thyroid Dysfunction and Anemia: A Prospective Cohort Study and a Systematic Review.[Subclinical hypothyroidism : should we still treat elderly patients? Clinical implications of a new trial in primary care].[2018 new recommendations for dyslipidemia : a critical review of evidence].Association of Stress Biomarkers With 30-Day Unplanned Readmission and Death.Prevalence of potentially inappropriate prescribing in a subpopulation of older European clinical trial participants: a cross-sectional study.[Immunization guidelines regarding patients with a chronic disease]Influence of peripheral arterial occlusive disease on the Neuropad(®) test performance in patients with diabetesAssociation of peripheral neuropathy with circulating advanced glycation end products, soluble receptor for advanced glycation end products and other risk factors in patients with type 2 diabetesBelow-knee arterial calcification in type 2 diabetes: association with receptor activator of nuclear factor κB ligand, osteoprotegerin, and neuropathyHigher parathyroid hormone levels are associated with increased below-the-knee arterial calcification in type 2 diabetes[Recommendations for management of dyslipidemia in 2016 in Switzerland]Inactive matrix gla protein plasma levels are associated with peripheral neuropathy in Type 2 diabetesPatterns of multimorbidity in medical inpatients: a multinational retrospective cohort studyMultimorbidity and healthcare resource utilization in Switzerland: a multicentre cohort studyPatterns of multimorbidity associated with 30-day readmission: a multinational study
P50
Q33595040-FD1D2B5C-3C5F-4D9B-BC13-2D80C6AE7169Q37644184-9C1AC480-5558-4C7B-A422-B2DCEAE48CFEQ38798082-512D3837-8C55-4A05-845C-7B991D8EFD02Q38833576-794F308E-9D29-4A07-B169-CEF5CCC1A097Q39487817-4105535C-2529-49BB-A61B-1F791A34203EQ39517607-0515A270-2B78-480A-BD37-39DC7DEBCD27Q39690734-C06B864C-D4D5-4C0C-9D63-630E44526F98Q40246242-81972BED-9A65-4914-8F1C-33AE106D02FBQ40794255-33988A24-B0CF-48FF-8565-23156E5AE113Q41054504-5448A3AB-3067-410F-85F7-87F220D5E265Q43124536-16169809-5F68-4690-9B3A-536AAA90BEA3Q44882288-789DB13A-A188-4680-9828-89B893D83B13Q46074511-EAD56CA4-4E29-411C-B356-81B6DB65B101Q46570310-C1D948C0-A8B7-4221-AF29-BF9C3E6BA59AQ47101110-1199D60A-B6A3-4252-8084-2C691DE675C3Q52598282-590B9BF5-97CB-4274-8ED8-9ECE19CFB167Q52681658-209202AE-5FFF-4A29-92F7-97D949E85C2DQ52681660-3AB283B1-BEEA-4241-A417-83B16903EADDQ53167373-0ED12FB4-392F-429B-B297-756C9001ADC3Q53835712-22B65F5F-5515-4967-BBD5-58B7B0F97CB8Q84224433-5368DB8A-33A5-4F1B-861E-F5C7493724F7Q86092367-F7000F3E-74D0-45E6-8E75-18E89E6A187EQ87140544-78853C56-1121-4C72-A5E1-3CDEDE4E3028Q87384830-1F7CA921-DE3A-4FFC-BCA8-A97CCBF9A952Q88287852-3104F825-E385-42CA-8478-EC3EC2072B64Q89247730-FC8196D8-6150-493C-8ECF-3215C3646883Q89857321-07855F57-447C-4110-8DE2-3AD080BD56CDQ90374430-3C9B5F84-F0F8-40AA-A790-A6F1B29DCB2BQ90777963-BAB31A77-F17F-42CE-879D-F97FC4BB18C4Q92726652-8B4C5580-8C29-4001-8268-65F61E295AA0
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Carole E Aubert
@ast
Carole E Aubert
@en
Carole E Aubert
@es
Carole E Aubert
@nl
Carole E Aubert
@sl
type
label
Carole E Aubert
@ast
Carole E Aubert
@en
Carole E Aubert
@es
Carole E Aubert
@nl
Carole E Aubert
@sl
prefLabel
Carole E Aubert
@ast
Carole E Aubert
@en
Carole E Aubert
@es
Carole E Aubert
@nl
Carole E Aubert
@sl
P106
P21
P31
P496
0000-0001-8325-8784